We resolved a complex case of Infectious Bronchitis in laying hens with a tailor-made biological product

{"ops":[{"insert":"Benten Biotech announced the results of a high-impact health case in egg-laying hens, in which the development of a customized biological product resolved a persistent case of "},{"attributes":{"bold":true},"insert":"Infectious Bronchitis (IBV)"},{"insert":". The problem manifested as sustained mortality and a 5–8% drop in egg production, compromising the operational stability of the affected farm.\n\nThis case, which occurred several years ago and is representative of a recurring trend in the industry, highlights the growing importance of "},{"attributes":{"bold":true},"insert":"identifying viral variants that fall outside the spectrum of protection offered by commercial vaccines"},{"insert":" and of providing specific biotechnological solutions for each production situation.\n\nA productive framework that did not respond to traditional methods"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nThe affected company maintained comprehensive vaccination programs and good management practices. However, production indicators continued to deteriorate. Key observations included:\n\nDaily mortality exceeding expected levels."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Sustained decline in egg production."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Increased proportion of low-quality eggs."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Previous diagnoses without a conclusive cause."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"\nThis type of scenario is frequently observed in modern poultry farming, where seemingly minor variations can mask highly complex viral challenges.\n\nExpanded diagnosis: identify the actual variant that was circulating in the field"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nFaced with the persistent symptoms, Benten Biotech implemented an expanded diagnostic approach based on more sensitive and comprehensive molecular techniques.\n\nThe analysis revealed a critical finding: the population was encountering an IBV genotype not represented in the commercially available vaccines.\n\nAlthough the vaccination protocols were being followed correctly, the protection was insufficient because the circulating variant exhibited significant antigenic divergence compared to the immune spectrum of the available vaccines.\n\nThe Benten differential: converting molecular data into a tailor-made biologic"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nAfter characterizing the variant, Benten Biotech activated its main technological strength: the ability to transform molecular information into a biological solution specifically designed for the identified problem.\n\nThe process included:\n\nDesign of a specific biologic"},{"attributes":{"header":3},"insert":"\n"},{"insert":"Formulated based on the actual antigenic profile of the virus identified in the field.\n\nStrategic integration into the health plan"},{"attributes":{"header":3},"insert":"\n"},{"insert":"Coordinated work with the client's veterinary team to adjust schedules, boosters, and synergies with existing commercial vaccines.\n\nOngoing technical support"},{"attributes":{"header":3},"insert":"\n"},{"insert":"Follow-up monitoring to ensure complete control of the challenge and the productive stability of the system.\n\n“The main challenge in these cases is closing the gap between the variant that is actually circulating and the available tools. When we develop a biologic that exactly matches the virus in the field, the health response is consistent and production recovers,” stated DMV Esteban Guerra, Director of Benten Biotech.\n\nResults: productive recovery and health stability"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nThe incorporation of the customized biological product into the health program resulted in:\n\nA return to physiological mortality levels."},{"attributes":{"list":"bullet"},"insert":"\n"},{"attributes":{"bold":true},"insert":"A recovery of the 5–8% of egg production"},{"insert":" previously lost."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Stabilization of egg quality."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Reduction of variability between batches."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Elimination of unnecessary antibiotic treatments."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Restoration of operational predictability, a key attribute in intensive egg-laying systems."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"\nThe problem, which persisted for several weeks before its true cause was identified, did not recur once the specific biological product was integrated.\n\nCommitment to precision solutions for modern poultry farming"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nThis case is yet another example of Benten Biotech's role as a strategic partner for intensive production systems in the region, offering:\n"},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Advanced diagnostics based on data and molecular analysis."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Custom-developed biologics, tailored to the actual circulating variant."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"Ongoing technical support to guarantee health stability and production competitiveness."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"\n“"},{"attributes":{"bold":true},"insert":"Today's poultry industry demands precision solutions."},{"insert":" Our responsibility is to provide applied science that allows each integrated operation to maintain health stability and competitiveness in an environment where viruses are constantly evolving,” added Esteban Guerra.\n"}]}